Muscarinic cholinergic receptor (M2) plays a crucial role in the development of myopia in mice

DMM Disease Models and Mechanisms

Volumn 6, Issue 5, 2013, Pages 1146-1158

  Barathi, Veluchamy A ^a,b,c   Kwan, Jia Lin ^a   Tan, Queenie S W ^a   Weon, Sung Rhan ^a   Seet, Li Fong ^a,b   Goh, Liang Kee ^b,c   Vithana, Eranga N ^a,b,c   Beuerman, Roger W ^a,b,c  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 5; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; MOUSE; MUSCARINIC M2 RECEPTOR GENE; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERA; UPREGULATION; VITREOUS BODY;

ADULT; AGED; ALKALOIDS; ANIMALS; CELL PROLIFERATION; COLLAGEN; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBROBLASTS; FURANS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, KNOCKOUT; MIDDLE AGED; MYOPIA; NAPHTHALENES; PIPERIDINES; PIRENZEPINE; RECEPTOR, MUSCARINIC M2; RNA, SMALL INTERFERING; SCLERA; UP-REGULATION;

EID: 84883849692     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010967     Document Type: Article

References (63)

1. Avetisov, E. S., Savitskaya, N. F., Vinetskaya, M. I. and Iomdina, E. N. (1983). A study of biochemical and biomechanical qualities of normal and myopic eye sclera in humans of different age groups. Metab. Pediatr. Syst. Ophthalmol. 7, 183-188.
2. Barathi, V. A. and Beuerman, R. W. (2011). Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment. Mol. Vis. 17, 680-692.
3. Barathi, V. A., Boopathi, V. G., Yap, E. P. and Beuerman, R. W. (2008). Two models of experimental myopia in the mouse. Vision Res. 48, 904-916.
4. Barathi, V. A., Weon, S. R. and Beuerman, R. W. (2009a). Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation. Mol. Vis. 15, 1277-1293.
5. Barathi, V. A., Beuerman, R. W. and Schaeffel, F. (2009b). Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice. Vision Res. 49, 383-387.
6. Birk, D. E., Zycband, E. I., Winkelmann, D. A. and Trelstad, R. L. (1990). Collagen fibrillogenesis in situ. Discontinuous segmental assembly in extracellular compartments. Ann. N. Y. Acad. Sci. 580, 176-194.
7. Bitzer, M., Kovacs, B., Feldkaemper, M. and Schaeffel, F. (2006). Effects of muscarinic antagonists on ZENK expression in the chicken retina. Exp. Eye Res. 82, 379-388.
8. Caulfield, M. P. and Birdsall, N. J. (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50, 279-290.
9. Chow, Y. C., Dhillon, B., Chew, P. T. and Chew, S. J. (1990). Refractive errors in Singapore medical students. Singapore Med. J. 31, 472-473.
10. Chua, W. H., Balakrishnan, V., Chan, Y. H., Tong, L., Ling, Y., Quah, B. L. and Tan, D. (2006). Atropine for the treatment of childhood myopia. Ophthalmology 113, 2285-2291.
11. Cottriall, C. L., Truong, H. T. and McBrien, N. A. (2001). Inhibition of myopia development in chicks using himbacine: a role for M(4) receptors? Neuroreport 12, 2453-2456.
12. Curtin, B. 1985. The Myopias: Basic Science and Clinical Management. New York, NY: Harper & Row.
13. Dirani, M., Chan, Y. H., Gazzard, G., Hornbeak, D. M., Leo, S. W., Selvaraj, P., Zhou, B., Young, T. L., Mitchell, P., Varma, R. et al. (2010). Prevalence of refractive error in Singaporean Chinese children: the strabismus, amblyopia, and refractive error in young Singaporean Children (STARS) study. Invest. Ophthalmol. Vis. Sci. 51, 1348-1355.
14. Fang, P. C., Chung, M. Y., Yu, H. J. and Wu, P. C. (2010). Prevention of myopia onset with 0.025% atropine in premyopic children. J. Ocul. Pharmacol. Ther. 26, 341-345.
15. Faulkner, A.E., Kim, M. K., Iuvone, P. M. and Pardue M. T. (2007). Head-mounted goggles for murine form deprivation myopia. J. Neurosci. Methods. 30, 96-100.
16. Fernández-Medarde, A., Barhoum, R., Riquelme, R., Porteros, A., Núñez, A., de Luis, A., de Las Rivas, J., de la Villa, P., Varela-Nieto, I. and Santos, E. (2009). RasGRF1 disruption causes retinal photoreception defects and associated transcriptomic alterations. J. Neurochem. 110, 641-652.
17. Friedman, Z., Hackett, S. F. and Campochiaro, P. A. (1988). Human retinal pigment epithelial cells possess muscarinic receptors coupled to calcium mobilization. Brain Res. 446, 11-16.
18. Ganesan, P. and Wildsoet, C. F. (2010). Pharmaceutical intervention for myopia control. Expert Rev. Ophthalmol. 5, 759-787.
19. Gentle, A., Liu, Y., Martin, J. E., Conti, G. L. and McBrien, N. A. (2003). Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J. Biol. Chem. 278, 16587-16594.
20. Gosens, R., Zaagsma, J., Meurs, H. and Halayko A. J. (2006). Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res. 7, 73.
21. Gwiazda, J. (2009). Treatment options for myopia. Optom. Vis. Sci. 86, 624-628.
22. Hotchkiss, M. L. and Fine, S. L. (1981). Pathologic myopia and choroidal neovascularization. Am. J. Ophthalmol. 91, 177-183.
23. Hulme, E. C., Birdsall, N. J. M. and Buckley, N. J. (1990). Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30, 633-673.
24. Hysi, P. G., Young, T. L., Mackey, D. A., Andrew, T., Fernández-Medarde, A., Solouki, A. M., Hewitt, A. W., Macgregor, S., Vingerling, J. R., Li, Y. J. et al. (2010). A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25. Nat. Genet. 42, 902-905.
25. Javitt, J. C. and Chiang, Y. P. (1994). The socioeconomic aspects of laser refractive surgery. Arch. Ophthalmol. 112, 1526-1530.
26. Jobling, A. I., Nguyen, M., Gentle, A. and McBrien, N. A. (2004). Isoform-specific changes in scleral transforming growth factor-beta expression and the regulation of collagen synthesis during myopia progression. J. Biol. Chem. 279, 18121-18126.
27. Li, Y. J., Goh, L., Khor, C. C., Fan, Q., Yu, M., Han, S., Sim, X., Ong, R. T., Wong, T. Y., Vithana, E. N. et al. (2010). Genome-wide association studies reveal genetic variants in CTNND2 for high myopia in Singapore Chinese. Ophthalmology 118, 368-375
28. Lin, L. L., Chen, C. J., Hung, P. T. and Ko, L. S. (1988). Nation-wide survey of myopia among schoolchildren in Taiwan, 1986. Acta Ophthalmol. Suppl. 185, 29-33.
29. Lind, G. J., Chew, S. J., Marzani, D. and Wallman, J. (1998). Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest. Ophthalmol. Vis. Sci. 39, 2217-2231.
30. Liu, S., Li, J., Tan, D. T. and Beuerman, R. W. (2007a). The eyelid margin: a transitional zone for 2 epithelial phenotypes. Arch. Ophthalmol. 125, 523-532.
31. Luft, W. A., Ming, Y. and Stell, W. K. (2003). Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest. Ophthalmol. Vis. Sci. 44, 1330-1338.
32. Matsui, M., Motomura, D., Fujikawa, T., Jiang, J., Takahashi, S., Manabe, T. and Taketo, M. M. (2002). Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J. Neurosci. 22, 10627-10632.
33. McBrien, N. A. and Gentle, A. (2001). The role of visual information in the control of scleral matrix biology in myopia. Curr. Eye Res. 23, 313-319.
34. McBrien, N. A. and Gentle, A. (2003). Role of the sclera in the development and pathological complications of myopia. Prog. Retin. Eye Res. 22, 307-338.
35. McBrien, N. A., Metlapally, R., Jobling, A. I. and Gentle, A. (2006). Expression of collagen-binding integrin receptors in the mammalian sclera and their regulation during the development of myopia. Invest. Ophthalmol. Vis. Sci. 47, 4674-4682.
36. McBrien, N. A., Jobling, A. I. and Gentle, A. (2009a). Biomechanics of the sclera in myopia: extracellular and cellular factors. Optom. Vis. Sci. 86, E23-E30. (Review).
37. McBrien, N. A., Jobling, A. I., Truong, H. T., Cottriall, C. L. and Gentle, A. (2009b). Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia. Mol. Vis. 15, 464-475.
38. Metlapally, R., Li, Y. J., Tran-Viet, K. N., Bulusu, A., White, T. R., Ellis, J., Kao, D. and Young, T. L. (2008). Common MFRP sequence variants are not associated with moderate to high hyperopia, isolated microphthalmia, and high myopia. Mol. Vis. 14, 387-393.
39. Morgan, I. G., Ohno-Matsui, K. and Saw, S. M. (2012). Myopia. Lancet 379, 1739-1748.
40. Norton, T. T. and Rada, J. A. (1995). Reduced extracellular matrix in mammalian sclera with induced myopia. Vision Res. 35, 1271-1281.
41. Pan, C. W., Wong, T. Y., Lavanya, R., Wu, R. Y., Zheng, Y. F., Lin, X. Y., Mitchell, P., Aung, T. and Saw, S. M. (2011). Prevalence and risk factors for refractive errors in Indians: the Singapore Indian Eye Study (SINDI). Invest. Ophthalmol. Vis. Sci. 52, 3166-3173.
42. Qu, J., Zhou, X., Xie, R., Zhang, L., Hu, D., Li, H. and Lu, F. (2006). The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists. Curr. Eye Res. 31, 587-597.
43. Rada, J. A., Nickla, D. L. and Troilo, D. (2000). Decreased proteoglycan synthesis associated with form deprivation myopia in mature primate eyes. Invest. Ophthalmol. Vis. Sci. 41, 2050-2058.
44. Rada, J. A., Shelton, S. and Norton, T. T. (2006). The sclera and myopia. Exp. Eye Res. 82, 185-200.
45. Saw, S. M., Katz, J., Schein, O. D., Chew, S. J. and Chan, T. K. (1996). Epidemiology of myopia. Epidemiol. Rev. 18, 175-187.
46. Saw, S. M., Gazzard, G., Au Eong, K. G. and Tan, D. T. (2002). Myopia: attempts to arrest progression. Br. J. Ophthalmol. 86, 1306-1311.
47. Saw, S. M., Chan, Y. H., Wong, W. L., Shankar, A., Sandar, M., Aung, T., Tan, D. T., Mitchell, P. and Wong, T. Y. (2008). Prevalence and risk factors for refractive errors in the Singapore Malay Eye Survey. Ophthalmology 115, 1713-1719.
48. Schaeffel, F., Burkhardt, E., Howland, H. C. and Williams, R. W. (2004). Measurement of refractive state and deprivation myopia in two strains of mice. Optom. Vis. Sci. 81, 99-110.
49. Seet, B., Wong, T. Y., Tan, D. T., Saw, S. M., Balakrishnan, V., Lee, L. K. and Lim, A. S. (2001). Myopia in Singapore: taking a public health approach. Br. J. Ophthalmol. 85, 521-526.
50. Siatkowski, R. M., Cotter, S. A., Crockett, R. S., Miller, J. M., Novack, G. D., Zadnik, K.; U.S. Pirenzepine Study Group (2008). Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. J. AAPOS 12, 332-339.
51. Siegwart, J. T., Jr and Norton, T. T. (2001). Steady state mRNA levels in tree shrew sclera with form-deprivation myopia and during recovery. Invest. Ophthalmol. Vis. Sci. 42, 1153-1159.
52. Siegwart, J. T., Jr and Strang, C. E. (2007). Selective modulation of scleral proteoglycan mRNA levels during minus lens compensation and recovery. Mol. Vis. 13, 1878-1886.
53. Solouki, A. M., Verhoeven, V. J., van Duijn, C. M., Verkerk, A. J., Ikram, M. K., Hysi, P. G., Despriet, D. D., van Koolwijk, L. M., Ho, L., Ramdas, W. D. et al. (2010). A genome-wide association study identifies a susceptibility locus for refractive errors and myopia at 15q14. Nat. Genet. 42, 897-901.
54. Tan, D. T., Lam, D. S., Chua, W. H., Shu-Ping, D. F., Crockett, R. S. and Asian Pirenzepine Study Group. ( (2005). One-year multicenter, double-masked, placebocontrolled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology 112, 84-91.
55. Tong, L., Huang, X. L., Koh, A. L., Zhang, X., Tan, D. T. and Chua, W. H. (2009). Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology 116, 572-579.
56. Unno, T., Matsuyama, H., Sakamoto, T., Uchiyama, M., Izumi, Y., Okamoto, H., Yamada, M., Wess, J. and Komori, S. (2005). M(2) and M(3) muscarinic receptormediated contractions in longitudinal smooth muscle of the ileum studied with receptor knockout mice. Br. J. Pharmacol. 146, 98-108.
57. Vitale, S., Cotch, M. F., Sperduto, R. and Ellwein, L. (2006). Costs of refractive correction of distance vision impairment in the United States, 1999-2002. Ophthalmology 113, 2163-2170.
58. Vitale, S., Ellwein, L., Cotch, M. F., Ferris, F. L., III and Sperduto, R. (2008). Prevalence of refractive error in the United States, 1999-2004. Arch. Ophthalmol. 126, 1111-1119.
59. Wess, J., Eglen, R. M. and Gautam, D. (2007). Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat. Rev. Drug Discov. 6, 721-733.
60. Wong, T. Y. and Saw, S. M. (2004). Issues and challenges for myopia research. Ann. Acad. Med. Singapore 33, 1-3.
61. Wong, T. Y., Foster, P. J., Hee, J., Ng, T. P., Tielsch, J. M., Chew, S. J., Johnson, G. J. and Seah, S. K. (2000). Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest. Ophthalmol. Vis. Sci. 41, 2486-2494.
62. Zhao, C., Wang, F., Zhang, Y., Wen, Y., Su, Y., Zhang, C., Sui, R., Xu, F., Ding, J. and Dong, F. (2012). A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalities. Mol. Vis. 18, 2205-2212.
63. Zhou, X., Ji, F., An, J., Zhao, F., Shi, F., Huang, F., Li, Y., Jiao, S., Yan, D., Chen, X. et al. (2012). Experimental murine myopia induces collagen type Iα1 (COL1A1) DNA methylation and altered COL1A1 messenger RNA expression in sclera. Mol. Vis. 18, 1312-1324.